AstraZeneca PLC - Asset Resilience Ratio

Latest as of September 2025: 0.03%

AstraZeneca PLC (ZEGA) has an Asset Resilience Ratio of 0.03% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ZEGA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€39.00 Million

≈ $45.60 Million USD Cash + Short-term Investments

Total Assets

€114.46 Billion

≈ $133.81 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how AstraZeneca PLC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ZEGA total asset value.

Liquid Assets Composition Over Time

This chart breaks down AstraZeneca PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore ZEGA long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€39.00 Million	0.03%
Total Liquid Assets	€39.00 Million	0.03%

Asset Resilience Insights

Limited Liquidity: AstraZeneca PLC maintains only 0.03% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

AstraZeneca PLC Industry Peers by Asset Resilience Ratio

Compare AstraZeneca PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.33%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	0.06%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.33%
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	0.00%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%

Annual Asset Resilience Ratio for AstraZeneca PLC (2014–2024)

The table below shows the annual Asset Resilience Ratio data for AstraZeneca PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.16%	€166.00 Million ≈ $194.07 Million	€104.03 Billion ≈ $121.63 Billion	+0.14pp
2023-12-31	0.02%	€20.00 Million ≈ $23.38 Million	€101.12 Billion ≈ $118.22 Billion	-0.23pp
2022-12-31	0.25%	€239.00 Million ≈ $279.42 Million	€96.48 Billion ≈ $112.80 Billion	+0.18pp
2021-12-31	0.07%	€69.00 Million ≈ $80.67 Million	€105.36 Billion ≈ $123.18 Billion	-0.17pp
2020-12-31	0.24%	€160.00 Million ≈ $187.06 Million	€66.73 Billion ≈ $78.01 Billion	-1.08pp
2019-12-31	1.32%	€811.00 Million ≈ $948.14 Million	€61.38 Billion ≈ $71.76 Billion	-0.01pp
2018-12-31	1.33%	€809.00 Million ≈ $945.81 Million	€60.65 Billion ≈ $70.91 Billion	-0.61pp
2017-12-31	1.94%	€1.23 Billion ≈ $1.44 Billion	€63.35 Billion ≈ $74.07 Billion	+0.53pp
2016-12-31	1.41%	€884.00 Million ≈ $1.03 Billion	€62.53 Billion ≈ $73.10 Billion	+0.39pp
2015-12-31	1.02%	€613.00 Million ≈ $716.66 Million	€60.06 Billion ≈ $70.21 Billion	+0.99pp
2014-12-31	0.03%	€20.00 Million ≈ $23.38 Million	€58.59 Billion ≈ $68.50 Billion	--

pp = percentage points

About AstraZeneca PLC

F:ZEGA Germany Drug Manufacturers - General

Market Cap

$273.68 Billion

€234.09 Billion EUR

Market Cap Rank

#73 Global

#6 in Germany

Share Price

€75.50

Change (1 day)

-3.82%

52-Week Range

€62.50 - €82.50

All Time High

€82.50